Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Batificaban for antithrombotic therapy in ACS patients undergoing PCI
CTR20130809Phase 3Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of batificaban in acute coronary syndrome (ACS), unstable angina, Non-ST-segment elevation myocardial infarction (NSTEMI), sponsored by Bio-Thera Solutions, Ltd.. Started May 2018; status: completed.
02
Drugs
batificaban
03
Conditions
acute coronary syndrome (ACS)unstable anginaNon-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on CTR20130809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130809.